Javascript must be enabled to continue!
KSHV Terminal Repeat Regulates Inducible Lytic Gene Promoters
View through CrossRef
Summary
The Kaposi’s sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140 kb unique coding region flanked by multiple copies of 0.8 kb terminal repeat (TR) sequence. While TR’s function in plasmid maintenance is well-established, TR’s transcription regulatory roles have not been fully explored. Here, we show KSHV TR is a large transcription regulatory domain.
A series of Cleavage Under Targets & Release Using Nuclease demonstrated that TR fragments are occupied by histone modifying enzymes that are known to interact with LANA in naturally infected cells, and the TR possessed characteristic enhancer histone modifications. The H3K4me3 and H3K27Ac modifications were conserved in unique region of the KSHV genome among naturally infected cells, and the KSHV Origin of lytic replication (Ori-Lyt) showed similar protein and histone modification occupancies with TR’s. In the Ori-Lyt region, the LANA complex colocalizes with H3K27Ac-modified nucleosome along with paused RNA polymerase II, and two K-Rta recruitment sites frank the nucleosome. The isolated reporter assays demonstrated that neighboring TR fragments enhanced viral lytic gene promoter activity independent of orientation in KSHV-infected and non-infected 293FT cells. K-Rta transactivation function was drastically enhanced with TR, while LANA acquired promoter repression function with TR. KSHV TR is, therefore a regulatory domain for KSHV inducible genes. However, in contrast to cellular enhancers that are bound by multiple transcription factors, perhaps the KSHV enhancer is predominantly regulated by the LANA nuclear body with TR. KSHV evolved a clever mechanism to tightly control the latency-lytic switch with the TR/LANA complex.
Importance
Enhancers are a crucial regulator of differential gene expression programs. Enhancer is the cis-regulatory sequences that determine target genes’ spatiotemporal and quantitative expression. Here, we show that KSHV terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters. KSHV enhancer is occupied by LANA and its interacting proteins, such as CHD4, and CHD4 is known to restrict enhancers to access promoters for activation. This study thus proposes a new latency-lytic switch model in which TR accessibility to the KSHV gene promoters regulates lytic gene transcription.
Title: KSHV Terminal Repeat Regulates Inducible Lytic Gene Promoters
Description:
Summary
The Kaposi’s sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140 kb unique coding region flanked by multiple copies of 0.
8 kb terminal repeat (TR) sequence.
While TR’s function in plasmid maintenance is well-established, TR’s transcription regulatory roles have not been fully explored.
Here, we show KSHV TR is a large transcription regulatory domain.
A series of Cleavage Under Targets & Release Using Nuclease demonstrated that TR fragments are occupied by histone modifying enzymes that are known to interact with LANA in naturally infected cells, and the TR possessed characteristic enhancer histone modifications.
The H3K4me3 and H3K27Ac modifications were conserved in unique region of the KSHV genome among naturally infected cells, and the KSHV Origin of lytic replication (Ori-Lyt) showed similar protein and histone modification occupancies with TR’s.
In the Ori-Lyt region, the LANA complex colocalizes with H3K27Ac-modified nucleosome along with paused RNA polymerase II, and two K-Rta recruitment sites frank the nucleosome.
The isolated reporter assays demonstrated that neighboring TR fragments enhanced viral lytic gene promoter activity independent of orientation in KSHV-infected and non-infected 293FT cells.
K-Rta transactivation function was drastically enhanced with TR, while LANA acquired promoter repression function with TR.
KSHV TR is, therefore a regulatory domain for KSHV inducible genes.
However, in contrast to cellular enhancers that are bound by multiple transcription factors, perhaps the KSHV enhancer is predominantly regulated by the LANA nuclear body with TR.
KSHV evolved a clever mechanism to tightly control the latency-lytic switch with the TR/LANA complex.
Importance
Enhancers are a crucial regulator of differential gene expression programs.
Enhancer is the cis-regulatory sequences that determine target genes’ spatiotemporal and quantitative expression.
Here, we show that KSHV terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters.
KSHV enhancer is occupied by LANA and its interacting proteins, such as CHD4, and CHD4 is known to restrict enhancers to access promoters for activation.
This study thus proposes a new latency-lytic switch model in which TR accessibility to the KSHV gene promoters regulates lytic gene transcription.
Related Results
Studies on Gene Enhancer with KSHV mini-chromatin
Studies on Gene Enhancer with KSHV mini-chromatin
Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) genome contains a terminal repeats (TR) sequence. Previous studies demonstrated that KSHV...
METTL16 controls Kaposi’s sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle
METTL16 controls Kaposi’s sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle
AbstractOncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases, both of which are important for the development of KSHV-related ca...
METTL16 Controls Kaposi’s Sarcoma-Associated Herpesvirus Replication by Regulating
S
-Adenosylmethionine Cycle
METTL16 Controls Kaposi’s Sarcoma-Associated Herpesvirus Replication by Regulating
S
-Adenosylmethionine Cycle
Abstract
Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases, both of which are important fo...
Kaposi sarcoma-associated herpesvirus infection in HIV patients: potential role of HIV-associated extracellular vesicles
Kaposi sarcoma-associated herpesvirus infection in HIV patients: potential role of HIV-associated extracellular vesicles
Abstract
Kaposi sarcoma-associated herpesvirus (KSHV) is the causal agent for Kaposi sarcoma (KS), the most common malignancy in people living with HIV/AIDS. The or...
KSHV TR deletion episomes uncover enhancer–promoter dynamics in gene regulation
KSHV TR deletion episomes uncover enhancer–promoter dynamics in gene regulation
Kaposi’s sarcoma-associated herpesvirus (KSHV) genome contains a terminal repeats (TR) sequence. Previous studies demonstrated that KSHV TR functions as a gene enhancer for inducib...
Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
Enhancers are a crucial regulator of differential gene expression programs. Enhancers are the cis-regulatory sequences determining target genes’ spatiotemporal and quantitative exp...
Global Changes in Kaposi's Sarcoma-Associated Virus Gene Expression Patterns following Expression of a Tetracycline-Inducible Rta Transactivator
Global Changes in Kaposi's Sarcoma-Associated Virus Gene Expression Patterns following Expression of a Tetracycline-Inducible Rta Transactivator
ABSTRACT
An important step in the herpesvirus life cycle is the switch from latency to lytic reactivation. In order to study the life cycle of Kaposi's sarcoma-associated...
Abstract 3721: The transcriptional signature of KSHV infection in the guinea pig host
Abstract 3721: The transcriptional signature of KSHV infection in the guinea pig host
Introduction:
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a human oncogenic virus implicated in various malignancies, including Kaposi’s sarcoma, primary ef...

